Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Serstech AB is a Swedish company that operates within the technology sector, specializing in the development and production of portable chemical analyzers. These devices serve a critical purpose in the identification of hazardous chemicals, providing real-time data to ensure safety and compliance in a range of environments. Serstech's primary focus is on creating solutions that facilitate quick, efficient, and accurate on-site chemical identification. This technology is particularly impactful in sectors such as security, law enforcement, and environmental protection, where rapid and reliable analysis of substances can be crucial. Key features of Serstech's products include their portability, ease of use, and the ability to link with databases for comprehensive analysis. These functionalities make them a valuable tool in scenarios that require immediate and informed decision-making capabilities. In the financial market, Serstech AB is noted for its innovative approach and contribution to enhancing operational safety standards across multiple industries. Its technological advancements highlight its role as a dynamic player in the field of chemical analysis and detection, bolstering its significance in the context of global safety and security protocols.
kr 0.02
+kr 0.00 (+8.49%)
EOD Jun 25, 2026 · Twelve Data
The business is unprofitable at the operating level (-73.95% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 26.2% YoY. Margins deteriorated 54.5pp alongside, both lines moving the wrong way.
ROIC dropped from -12.70% to -36.27%, capital efficiency is deteriorating. Negative free cash flow of -kr 37M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
kr 25M
▼ -26.2% YoY
Net Income (TTM)
-kr 35M
▼ -220.6% YoY
Op. Margin
-134.20%
▼ -54.5pp YoY
ROIC
-36.27%
▼ -23.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-kr 41M
▼ -340.5% YoY
Op. Cash Flow (TTM)
-kr 35M
▼ -290.4% YoY
Net Debt
-kr 10M
Net Cash Position
Cash & Equiv.
kr 10M
3Y CAGR: +31.1%
Continue Research
Serstech AB (SERT.XSTO)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Serstech AB scores 40/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Serstech AB scores 40 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a -134.2% operating margin and a -36.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh SERT.XSTO's valuation and scores 40/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.